Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23638466 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
Condition: Type 2 Diabetes
Interventions: Drug: Metformin;   Drug: Sulphonylurea;   Drug: Saxagliptin

Indicates status has not been verified in more than two years